000			01402cam a22003854a 4500
001			15472966
003			OSt
005			20250206094602.0
008			250206s2008 njua b 001 0 eng c
010			_a 2008938265 _z 2008938268
020			_a9781588296467
040			_aKABU _cKABU
050	0	0	_aRC271 _b.G46 2009
245	0	0	_aGenomics and pharmacogenomics in anticancer drug development and clinical response / _cedited by Federico Innocenti.
260			_aTotowa, NJ : _bHumana Press, _c2010
300			_axiv, 379p. :
490	1		_aCancer drug discovery and development
504			_aIncludes bibliographical references and index.
505	0		_aGenomic experimental approaches in oncology -- Pharmacogenomics of toxicity and response of chemotherapy -- Pharmacogenomics in clinical drug development in oncology.
650		0	_aCancer _xGenetic aspects.
650		0	_aCancer _xMolecular aspects.
650		0	_aGenomics.
650		0	_aPharmacogenomics.
650		0	_aDrug development.
650		0	_aAntineoplastic agents _xDevelopment.
650	1	2	_aAntineoplastic Agents.
650	2	2	_aGenomics.
650	2	2	_aNeoplasms _xdrug therapy.
650	2	2	_aNeoplasms _xgenetics.
650	2	2	_aPharmacogenetics _xmethods.
700	1		_aInnocenti, Federico. _eEditor
800			_aTeicher, Beverly A. _eEditor
830		0	_aCancer drug discovery and development.
942			_2lcc _cBK
999			_c20622 _d20621